Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haixia Su

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry|May 15, 2023
Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moietyMengwei Zhu, Tiantian Fu, Mengyuan You, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 7, 2025
Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L ProteaseHaixia Su, Guoqing Wu, Muya Xiong, et al.
European Journal of Medicinal Chemistry|May 30, 2023
Design, synthesis and biological evaluation of peptidomimetic benzothiazolyl ketones as 3CL<sup>pro</sup> inhibitors against SARS-CoV-2Hanxi Yang, Mengyuan You, Xiaoyang Shu, et al.
Antiviral Research|November 10, 2022
In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2Weijuan Shang, Wenhao Dai, Cheng Yao, et al.
Journal of Medicinal Chemistry|May 22, 2025
Development of Orally Bioavailable Octahydroindole-Based Peptidomimetic Derivative as a Broad-Spectrum Inhibitor against HCoV-OC43 and SARS-CoV-2Shulei Hu, Yumin Zhang, Chenchen Wang, et al.
European Journal of Medicinal Chemistry|November 21, 2020
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatmentRui Zhang, Heng Li, Xianglei Zhang, et al.
Iscience|February 15, 2020
Allosteric Regulation of Hsp90α's Activity by Small Molecules Targeting the Middle Domain of the ChaperoneChen Zhou, Chi Zhang, Hongwen Zhu, et al.
National Science Review|November 8, 2023
Multi-omics for COVID-19: driving development of therapeutics and vaccinesMengyu Guo, Muya Xiong, Jinying Peng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 13, 2025
Structure-Based Development of Ultra-Broad-Spectrum 3C-Like Protease InhibitorsHaixia Su, Tianqing Nie, Guofeng Chen, et al.
Journal of Medicinal Chemistry|August 18, 2023
Discovery and Mechanism Study of SARS-CoV-2 3C-like Protease Inhibitors with a New Reactive GroupPengxuan Ren, Hui Li, Tianqing Nie, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry|May 15, 2023
Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moietyMengwei Zhu, Tiantian Fu, Mengyuan You, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 7, 2025
Dynamic Cap-Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L ProteaseHaixia Su, Guoqing Wu, Muya Xiong, et al.
European Journal of Medicinal Chemistry|May 30, 2023
Design, synthesis and biological evaluation of peptidomimetic benzothiazolyl ketones as 3CL<sup>pro</sup> inhibitors against SARS-CoV-2Hanxi Yang, Mengyuan You, Xiaoyang Shu, et al.
Antiviral Research|November 10, 2022
In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2Weijuan Shang, Wenhao Dai, Cheng Yao, et al.
Journal of Medicinal Chemistry|May 22, 2025
Development of Orally Bioavailable Octahydroindole-Based Peptidomimetic Derivative as a Broad-Spectrum Inhibitor against HCoV-OC43 and SARS-CoV-2Shulei Hu, Yumin Zhang, Chenchen Wang, et al.
European Journal of Medicinal Chemistry|November 21, 2020
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatmentRui Zhang, Heng Li, Xianglei Zhang, et al.
Iscience|February 15, 2020
Allosteric Regulation of Hsp90α's Activity by Small Molecules Targeting the Middle Domain of the ChaperoneChen Zhou, Chi Zhang, Hongwen Zhu, et al.
National Science Review|November 8, 2023
Multi-omics for COVID-19: driving development of therapeutics and vaccinesMengyu Guo, Muya Xiong, Jinying Peng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 13, 2025
Structure-Based Development of Ultra-Broad-Spectrum 3C-Like Protease InhibitorsHaixia Su, Tianqing Nie, Guofeng Chen, et al.
Journal of Medicinal Chemistry|August 18, 2023
Discovery and Mechanism Study of SARS-CoV-2 3C-like Protease Inhibitors with a New Reactive GroupPengxuan Ren, Hui Li, Tianqing Nie, et al.
Pageof 8